SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.33
+0.38%Aug 6, 2026, 12:33 UTC
Sonoma Pharmaceuticals Inc. reported its first-quarter financial results, achieving record quarterly revenue and turning EBITDA positive for the first time, with a net loss of 9 cents per share compared to a loss of 76 cents per share a year earlier.